In patients with stroke or TIA and CYP2C19 loss-of-function alleles, ticagrelor vs. clopidogrel reduced 90-d stroke

被引：1
|
作者：
Joundi, Raed A. [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2022年 / 175卷 / 03期
关键词：
MINOR STROKE; ASPIRIN;
D O I：
10.7326/J22-0008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：JC30 / JC30
页数：1
相关论文
共 50 条
  • [21] Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial
    Xie, Xuewei
    Johnston, S. Claiborne
    Wang, Anxin
    Xu, Qin
    Bath, Philip M.
    Pan, Yuesong
    Li, Hao
    Lin, Jinxi
    Wang, Yilong
    Zhao, Xingquan
    Li, Zixiao
    Jiang, Yong
    Liu, Liping
    Xu, Anding
    Jing, Jing
    Meng, Xia
    Wang, Yongjun
    JAMA NETWORK OPEN, 2023, 6 (06) : e2317037
  • [22] Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial
    Hongliang Wu
    Huiqun Song
    Lianwei Dou
    Bo Gao
    Yan Pan
    Mei Dong
    Qi Chen
    Jiazhen Li
    Lixiang Song
    Chuanyu Liu
    Bing Li
    Wenzheng Chu
    BMC Neurology, 20
  • [23] Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations
    Narasimhalu, Kaavya
    Ang, Yoong Kwei
    Tan, Doreen Su Yin
    De Silva, Deidre Anne
    Tan, Kelvin Bryan
    CLINICAL DRUG INVESTIGATION, 2020, 40 (11) : 1063 - 1070
  • [24] Effectiveness and safety of high dose clopidogrel plus aspirin in ischemic stroke patients with the single CYP2C19 loss-of-function allele: a randomized trial
    Wu, Hongliang
    Song, Huiqun
    Dou, Lianwei
    Gao, Bo
    Pan, Yan
    Dong, Mei
    Chen, Qi
    Li, Jiazhen
    Song, Lixiang
    Liu, Chuanyu
    Li, Bing
    Chu, Wenzheng
    BMC NEUROLOGY, 2020, 20 (01)
  • [25] Cost Effectiveness of Genotype-Guided Antiplatelet Therapy in Asian Ischemic Stroke Patients: Ticagrelor as an Alternative to Clopidogrel in Patients with CYP2C19 Loss of Function Mutations
    Kaavya Narasimhalu
    Yoong Kwei Ang
    Doreen Su Yin Tan
    Deidre Anne De Silva
    Kelvin Bryan Tan
    Clinical Drug Investigation, 2020, 40 : 1063 - 1070
  • [26] EFFECT OF CLOPIDOGREL OR TICAGRELOR ON PCI PLATELET INHIBITION RATE IN PATIENTS WITH DIFFERENT CYP2C19 ALLELES
    Jiang, Zhen
    Li, Sai
    Li, Yinjun
    Jin, Xiaoyu
    Bao, Bo
    Wang, Yang
    ACTA MEDICA MEDITERRANEA, 2020, 36 (01): : 299 - 303
  • [27] CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients
    Yang Jie
    Zhao Hong-Dong
    Tan Jie
    Ding Yun-Long
    Zou Jian-Jun
    PHARMAZIE, 2013, 68 (03): : 183 - 186
  • [28] Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
    Changqing Li
    Weihua Jia
    Jian Li
    Fangfei Li
    Jing Ma
    Lichun Zhou
    BMC Neurology, 21
  • [29] Impact of CYP2C19 genotype in ischaemic stroke patients treated with clopidogrel
    Doney, A.
    Palmer, C.
    Morant, S.
    Flynn, R.
    MacDonald, T.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 29 - 29
  • [30] Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
    Li, Changqing
    Jia, Weihua
    Li, Jian
    Li, Fangfei
    Ma, Jing
    Zhou, Lichun
    BMC NEUROLOGY, 2021, 21 (01)
12345